改变遗传性脑疾病的结局。
Changing the outcome in genetic brain disorders.
机构信息
Cincinnati Children's Hospital, University of Cincinnati College of Medicine - Neurology, Cincinnati, OH, USA.
出版信息
Dev Med Child Neurol. 2022 Oct;64(10):1184-1185. doi: 10.1111/dmcn.15350. Epub 2022 Jul 22.
Abstract
This commentary is on the original articles by Wang et al. and Zhang et al. on pages 1230–1236 and 1237–1245 of this issue.
摘要
这篇评论是针对 Wang 等人和 Zhang 等人在本期第 1230-1236 页和第 1237-1245 页上的原始文章而写的。
相似文献
1
Changing the outcome in genetic brain disorders.改变遗传性脑疾病的结局。
Dev Med Child Neurol. 2022 Oct;64(10):1184-1185. doi: 10.1111/dmcn.15350. Epub 2022 Jul 22.
2
Neurodevelopment and the origins of brain disorders.神经发育与脑部疾病的起源
Neuropsychopharmacology. 2015 Jan;40(1):1-3. doi: 10.1038/npp.2014.237.
3
Gestational hypoxia and epigenetic programming of brain development disorders.孕期缺氧与脑发育障碍的表观遗传编程
Drug Discov Today. 2014 Dec;19(12):1883-96. doi: 10.1016/j.drudis.2014.09.010. Epub 2014 Sep 26.
4
Developing epigenetic diagnostics and therapeutics for brain disorders.开发用于脑部疾病的表观遗传学诊断和治疗方法。
Trends Mol Med. 2013 Dec;19(12):732-41. doi: 10.1016/j.molmed.2013.09.003. Epub 2013 Oct 18.
5
Brain plasticity, memory and neurological disorders: an epigenetic perspective.脑可塑性、记忆与神经障碍：表观遗传学视角
Neuroreport. 2010 Oct 6;21(14):909-13. doi: 10.1097/WNR.0b013e32833e9288.
6
Epigenetics in the nervous system.神经系统中的表观遗传学
J Neurosci. 2008 Nov 12;28(46):11753-9. doi: 10.1523/JNEUROSCI.3797-08.2008.
7
Stem Cell Technology for (Epi)genetic Brain Disorders.用于（表观）遗传脑疾病的干细胞技术
Adv Exp Med Biol. 2017;978:443-475. doi: 10.1007/978-3-319-53889-1_23.
8
Somatic cell genomics of brain disorders: a new opportunity to clarify genetic-environmental interactions.脑部疾病的体细胞基因组学：阐明基因与环境相互作用的新契机。
Cytogenet Genome Res. 2013;139(3):181-8. doi: 10.1159/000347053. Epub 2013 Feb 20.
9
Pharmacology of epigenetics in brain disorders.脑疾病中的表观遗传学药理学。
Br J Pharmacol. 2010 Jan 1;159(2):285-303. doi: 10.1111/j.1476-5381.2009.00526.x. Epub 2009 Dec 15.
10
[Role of epigenetic modification in higher brain dysfunction and aging].[表观遗传修饰在高级脑功能障碍与衰老中的作用]
Nihon Shinkei Seishin Yakurigaku Zasshi. 2012 Nov;32(5-6):275-80.
本文引用的文献
1
Prenatal diagnosis and intervention improve developmental outcomes and epilepsy prognosis in children with tuberous sclerosis complex.产前诊断与干预可改善结节性硬化症患儿的发育结局和癫痫预后。
Dev Med Child Neurol. 2022 Oct;64(10):1230-1236. doi: 10.1111/dmcn.15265. Epub 2022 May 25.
2
Perinatal adversities in tuberous sclerosis complex: Determinants and neurodevelopmental outcomes.结节性硬化症的围产期不良事件：决定因素与神经发育结局。
Dev Med Child Neurol. 2022 Oct;64(10):1237-1245. doi: 10.1111/dmcn.15224. Epub 2022 Apr 2.
3
Prenatal Sirolimus Treatment for Rhabdomyomas in Tuberous Sclerosis.产前西罗莫司治疗结节性硬化症中的横纹肌瘤。
Pediatr Neurol. 2021 Dec;125:26-31. doi: 10.1016/j.pediatrneurol.2021.09.014. Epub 2021 Sep 25.
4
Prevention of Epilepsy in Infants with Tuberous Sclerosis Complex in the EPISTOP Trial.EPISTOP 试验中婴儿结节性硬化症的癫痫预防。
Ann Neurol. 2021 Feb;89(2):304-314. doi: 10.1002/ana.25956. Epub 2020 Nov 27.
5
Influence of seizures on early development in tuberous sclerosis complex.癫痫发作对结节性硬化症早期发育的影响。
Epilepsy Behav. 2017 May;70(Pt A):245-252. doi: 10.1016/j.yebeh.2017.02.007. Epub 2017 Apr 28.
6
Cancer drugs to treat birth defects.用于治疗出生缺陷的癌症药物。
Nat Genet. 2007 Sep;39(9):1057-9. doi: 10.1038/ng0907-1057.
Zotero 插件